国产精品777,风韵少妇性饥渴推油按摩视频,24小时日本在线WWW免费的,波多野42部无码喷潮在线

您好,歡迎進(jìn)入上海力敏實(shí)業(yè)有限公司網(wǎng)站!
一鍵分享網(wǎng)站到:
您現(xiàn)在的位置:首頁(yè) >> 產(chǎn)品中心 >> 生化試劑、抗體、血清 >> 抗體/蛋白 >> santacruz SC-81805Talin-1 Antibody (YQ-16)

Talin-1 Antibody (YQ-16)

  • 更新時(shí)間:  2023-07-25
  • 產(chǎn)品型號(hào):  santacruz SC-81805
  • 簡(jiǎn)單描述
  • mouse monoclonal IgG3 provided at 100 µg/ml
    recommended for detection of Talin-1 of mouse, rat and human origin by WB, IP, IF, IHC(P) and ELISA
詳細(xì)介紹

SANTA CRUZ BIOTECHNOLOGY, INC.
Talin-1 (YQ-16): sc-81805
Santa Cruz Biotechnology, Inc. 1.800.457.3801 831.457.3800 831.457.3801 Europe +00800 4573 8000 49 6221 4503 0 www.scbt.com
BACKGROUND
Focal adhesions were identified as areas within the plasma membrane of
tissue culture cells that adhere tightly to the underlying substrate. In vivo,
these regions are involved in the adhesion of cells to the extracellular matrix.
Paxillin and vinculin are cytoskeletal, focal adhesion proteins that are components
of a protein complex that links the Actin network to the plasma
membrane. Vinculin binding sites have been identified on other cytoskeletal
proteins, including Talin-1 and α-actinin. In addition, vinculin, Talin-1, Talin-2
and α-actinin each contain Actin binding sites. Expression of vinculin, Talin-1
and Talin-2 have been shown to be affected by the level of Actin expression.
α-actinin has been shown to link Actin to integrins in the plasma membrane
through interactions with the vinculin and Talin complex or by a direct interaction
with integrin. Talin-2 is similar to Talin-1 but shows distinct patterns of
expression and cannot compensate for the loss of Talin-1.
REFERENCES
1. Burridge, K., et al. 1988. Focal adhesions: transmembrane junctions
between the extracellular matrix and the cytoskeleton. Annu. Rev. Cell
Biol. 4: 487-525.
2. Gilmore, A.P., et al. 1992. Further characterization of the Talin-binding site
in the cytoskeletal protein vinculin. J. Cell Sci. 103: 719-731.
3.Wood, C.K., et al. 1994. Characterisation of the paxillin-binding site and
the C-terminal focal adhesion targeting sequence in vinculin. J. Cell Sci.
107: 709-717.
4. Gluck, U., et al. 1994. Modulation of α-actinin levels affects cell motility
and confers tumorigenicity on 3T3 cells. J. Cell Sci. 107: 1773-1782.
5. Schevzov, G., et al. 1995. Impact of Actin gene expression on vinculin,
Talin, cell spreading, and motility. DNA Cell Biol. 14: 689-700.
6. Hemmings, L., et al. 1996. Talin contains three Actin-binding sites each of
which is adjacent to a vinculin-binding site. J. Cell Sci. 109: 2715-2726.
7. Gilmore, A.P., et al. 1996. Regulation of vinculin binding to Talin and Actin
by phosphatidyl-inositol-4-5-bisphosphate. Nature 381: 531-535.
CHROMOSOMAL LOCATION
Genetic locus: TLN1 (human) mapping to 9p13.3; Tln1 (mouse) mapping to
4 B1.
SOURCE
Talin-1 (YQ-16) is a mouse monoclonal antibody raised against recombinant
Talin-1 of human origin.
PRODUCT
Each vial contains 100 μg IgG3 in 1.0 ml PBS with < 0.1% sodium azide and
0.1% gelatin.
STORAGE
Store at 4° C, **DO NOT FREEZE**. Stable for one year from the date of
shipment. Non-hazardous. No MSDS required.
APPLICATIONS
Talin-1 (YQ-16) is recommended for detection of Talin-1 of mouse, rat and
human origin by Western Blotting (starting dilution 1:200, dilution range
1:100-1:1000), immunoprecipitation [1-2 μg per 100-500 μg of total protein
(1 ml of cell lysate)], immunofluorescence (starting dilution 1:50, dilution
range 1:50-1:500), immunohistochemistry (including paraffin-embedded
sections) (starting dilution 1:50, dilution range 1:50-1:500) and solid phase
ELISA (starting dilution 1:30, dilution range 1:30-1:3000).
Suitable for use as control antibody for Talin-1 siRNA (h): sc-36610, Talin-1
siRNA (m): sc-36611, Talin-1 shRNA Plasmid (h): sc-36610-SH, Talin-1 shRNA
Plasmid (m): sc-36611-SH, Talin-1 shRNA (h) Lentiviral Particles: sc-36610-V
and Talin-1 shRNA (m) Lentiviral Particles: sc-36611-V.
Molecular Weight of Talin-1: 230 kDa.
Positive Controls: RAW 264.7 whole cell lysate: sc-2211.
RECOMMENDED SECONDARY REAGENTS
To ensure optimal results, the following support (secondary) reagents are
recommended: 1) Western Blotting: use goat anti-mouse IgG-HRP: sc-2005
(dilution range: 1:2000-1:32,000) or Cruz Marker™ compatible goat antimouse
IgG-HRP: sc-2031 (dilution range: 1:2000-1:5000), Cruz Marker™
Molecular Weight Standards: sc-2035, TBS Blotto A Blocking Reagent:
sc-2333 and Western Blotting Luminol Reagent: sc-2048. 2) Immunoprecipitation:
use Protein A/G PLUS-Agarose: sc-2003 (0.5 ml agarose/2.0 ml).
3) Immunofluorescence: use goat anti-mouse IgG-FITC: sc-2010 (dilution
range: 1:100-1:400) or goat anti-mouse IgG-TR: sc-2781 (dilution range:
1:100-1:400) with UltraCruz™ Mounting Medium: sc-24941. 4) Immunohistochemistry:
use ImmunoCruz™: sc-2050 or ABC: sc-2017 mouse IgG
Staining Systems.
DATA
SELECT PRODUCT CITATIONS
1. Ah Kioon, M.D., et al. 2010. Adrenomedullin increases fibroblast-like synoviocyte
adhesion to extracellular matrix proteins by upregulating integrin
activation. Arthritis Res. Ther. 12: R190.
RESEARCH USE
For research use only, not for use in diagnostic procedures.

 

上海力敏實(shí)業(yè)有限公司代理santacruz產(chǎn)品,咨詢 
上海力敏實(shí)業(yè)有限公司代理santazruz產(chǎn)品,咨詢 


留言框

  • 產(chǎn)品:

  • 您的單位:

  • 您的姓名:

  • 聯(lián)系電話:

  • 常用郵箱:

  • 省份:

  • 詳細(xì)地址:

  • 補(bǔ)充說(shuō)明:

  • 驗(yàn)證碼:

    請(qǐng)輸入計(jì)算結(jié)果(填寫阿拉伯?dāng)?shù)字),如:三加四=7
无码GOGO大胆啪啪艺术| 国产欧美精品一区二区三区-老狼| 国产在线永久视频| 天天综合日日噜噜噜| 久久天堂视频| 奇米色777| 亚洲成a人片在线观| 午夜不卡在线| 国产v亚洲v天堂a无| 51精品少妇人妻AV一区二区| 囯产精品久久久久久久久免费蜜桃| 国产男女猛烈无遮挡A片软件| 小孩子禁止看的东西| 我和亲妺婷婷在浴室作爱经过| 日本韩国一级片| 大内密探之零零性性| 女人爽到高潮潮喷在线观看直播了| CHINESE熟女老女人HD| 日日干日日操| 国产精品v片在线观看不卡| 久久伊人热精品老鸭窝| 国产对白嫖老妇搡老太| 天天爱天天操天天射| 国产乱妇乱子视频在播放| 日本添下边无码视频| 少妇色情喷水又紧又爽小说| 双乳被一左一右吃着动态图| 第四色成人网| 国产成人亚洲合集青青草原精品| 黑人BBCVIDEOS极品| 亚洲欧美卡通动漫| 精品视频在线免费| 18GAY男同69亚洲帅男蓝宇| 久久久无码精品人妻一区| 中国一级特黄特级毛片| 女人被强╳到高潮喷水在线观看| 网禁拗女在稀缺视频网站| 久久久亚洲欧洲日产国码二区| 国产69精品久久久久乱码| 大象焦伊人在钱8| 第一次破了女处小红|